Vise Technologies Inc. Makes New $2.61 Million Investment in CME Group Inc. $CME

Vise Technologies Inc. purchased a new stake in CME Group Inc. (NASDAQ:CME) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 11,824 shares of the financial services provider’s stock, valued at approximately $2,611,000.

Several other institutional investors also recently modified their holdings of CME. Whipplewood Advisors LLC raised its stake in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after buying an additional 83 shares during the period. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC bought a new position in shares of CME Group during the 4th quarter worth approximately $28,000. Legacy Wealth Managment LLC ID increased its holdings in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the last quarter. Finally, Main Street Group LTD acquired a new position in shares of CME Group during the 1st quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $274.98 on Friday. The firm has a market cap of $98.88 billion, a P/E ratio of 23.32, a price-to-earnings-growth ratio of 3.16 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The business’s 50 day moving average is $251.17 and its 200-day moving average is $279.65.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the previous year, the company posted $2.96 EPS. Equities research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Wall Street Analyst Weigh In

CME has been the subject of several research reports. JPMorgan Chase & Co. raised their price target on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a report on Thursday, July 23rd. Morgan Stanley upped their price objective on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Piper Sandler dropped their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. The Goldman Sachs Group cut their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $288.56.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.